A 60-year-old male with castration-resistant prostate cancer with metastases to bone is found to have a genetic variant in BRCA2, increasing his risk of other cancers.
While genetic testing offers tangible benefits to patients, it’s often underutilized due to cost and accessibility barriers. Invitae is addressing these barriers with the Detect Hereditary Prostate Cancer Program which offers no-charge, sponsored genetic testing and genetic counseling to eligible patients.
Invitae takes patient privacy very seriously. For more information on how Invitae protects your privacy please follow this link.
Stage IIa, age at diagnosis 55 years or under
Stage IIb or IIc at any age
Stage III at any age
Stage IV at any age
Postmortem samples are not permitted through the program at this time
Gleason 6, age at diagnosis 55 or under
Gleason 7 or greater at any age
Metastatic disease at any age
Gleason undetermined, suspected low risk (stage IIa) or above at any age
If a positive result is identified, testing for your patient’s family members is available.
Simply follow the ordering instructions, selecting only the gene(s) you are interested in testing for the family member. The partner code will automatically be added with the order.
If you're a patient and believe you are eligible for this sponsored testing program, you have options:
Contact Genome Medical
(available in US only)
Schedule a genetic counseling session, by phone or video, with an expert who can review your testing options and place the order. There is a cost associated with the Genome Medical services, which may be covered under your health benefits.
Discuss the program with your doctor
If you already have a healthcare provider who can place this order, you can download this flyer to take to your own provider.
Find a local genetics provider
Search our genetics providers network to find a provider in your area. Please sign in, or create an account, to connect with our network of professionals. There may be a cost associated with the provider’s services.
While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US and Canada. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.
1. Nicolosi P, Ledet E, Yang S et al. JAMA Oncol. 2019 Apr 1;5(4):523-528.